AXON Axon Enterprise, Inc.
Axon Enterprise, Inc. provides public safety technology solutions in the United States and internationally. The company operates in two segments, Software and Services, and Connected Devices. The Software and Services segment develops, manufactures, and sells cloud-based software-as-a-service solutions to capture, store, manage, share, and analyze video and other digital evidence. This segment also offers Axon Evidence, Draft One, Axon Records, Axon Standards, Axon Fusus, Axon Assistant, and others. The Connected Devices segment engages in the development, manufacture, and sale of integrated hardware solutions, such as conducted energy devices under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone technologies, accessories, extended warranties, and related hardware products, as well as virtual reality training hardware. The company serves first responders across international, federal, state, and local governments, international governmental entities, commercial enterprises, and consumers through direct sales, distribution partners, and third-party resellers. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.…
Industry Peers
Aerospace & DefenseKey Statistics
About Axon Enterprise (NASDAQ: AXON)
›
Axon Enterprise (NASDAQ: AXON) is listed on Nasdaq, where its shares trade in USD. It belongs to the Aerospace & Defense industry, part of the Industrials sector, and reports about 5,100 employees.
The shares were at 306.98 USD on 19 November 2026, down 47.7% over 52 weeks. Its 52-week range is 291.11 USD to 665.07 USD: the price is 53.8% below the high and 5.5% above the low.
At a market capitalisation of 25.00B USD, it trades at 98.7 times trailing earnings and 32.5 times forward earnings. The median trailing P/E of its 19 largest Aerospace & Defense peers is 31.3, a premium of 215% for AXON.
Axon Enterprise reports return on equity of 3.8%, an operating margin of 1.5% and revenue up 27.9% year over year.
Its debt exceeds its cash by 1.33B USD, a debt-to-equity ratio of 0.59. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 19 analysts cover the stock, with an average rating of Buy; their mean price target of 541.32 USD is 76.3% above the current price. The next earnings report is expected on 24 February 2027.